GENETIC LINKS TO ANXIETY AND DEPRESSION STUDY (GLAD STUDY)

online

Who we are

An exciting opportunity to get involved in the largest ever study of anxiety and depression.

genetic links to anxiety and depression study (glad study) Logo

Description

What is the GLAD Study?

The GLAD study is a project set up to explore risk factors in individuals who have experienced depression and/or anxiety, including those with a diagnosis of bipolar disorder, OCD, or related disorders, at any times in their lives.

It is aims to better understand depression and anxiety in order to find and develop more effective treatments.  The GLAD Study is also part of the NIHR BioResource, which is a library of information about people's health aiming to support research in both physical and mental health.

Are you:

  • aged 16+
  • Living in the UK
  • Experienced clinical levels of depression and/or anxiety, or have experienced these in the past?

How do I take part in the GLAD study?

You can take part in the GLAD study by following the sign-up steps

  1. Register on our website www.gladstudy.org.uk and read the information sheet
  2. Provide your consent using our online form
  3. Complete an online questionnaire to see if you are eligible.  This takes around 30 minutes
  4. Send a saliva DNA sample through the post using the freepost envelope provided

Once you have completed these steps, you will be able to see information on the website about a number of optional questionnaires or other research studies that are being carried out.

Once you are enrolled in the GLAD study, you are free to withdraw at any time you choose.

Who do I contact if I have more questions?

If you are interested in joining the GLAD study but have more questions, you can visit our website or alternatively you can contact via our contact details or social media.

 


Contact Details

Contact name: GLAD Study

Email address: gladstudy@kcl.ac.uk

Phone number: 0800 634 4504 freephone or 0207 848 1638

Mobile number:


Locations

Address details:

online




Published: 09 November 2022